Acasti Pharma reported $17.3M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Acasti Pharma USD 17.3M 3.22M Sep/2025
Addus HomeCare USD 269.49M 8.83M Dec/2025
Amarin USD 649.88M 21.55M Dec/2025
Cassava Sciences USD 97.71M 11.2M Dec/2025
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Option Care Health USD 1.26B 17.8M Dec/2025
Organigram Holdings CAD 256.54M 28.35M Dec/2025
Tilray USD 729.32M 28.18M Sep/2025